Literature DB >> 28185215

The apoptotic inducible effects of salicylic acid on hepatoma cell line: relationship with nitric oxide signaling.

Yahui Liu1, Yong Wang2, Yue Hu3, Shuxiong Ge4, Keshi Li4, Shuangshuang Wang3, Li Li5.   

Abstract

Clinical and experimental data suggest that salicylic acid (SA) is tumor preventive and NO has a multitude of effects on tumor biology. Therefore, firstly, the aim of our study is to explore the important role of SA in apoptotic induction of liver cancer cells. Secondly, we investigate whether SA mediates the anti-tumor effects by NO signaling pathway. The liver cancer cell line was treated with different concentrations of SA. Cell proliferation was tested using MTS assay and cell apoptosis was assessed by flow cytometry. NO content and NOS activities were measured by biochemical assay. The anti- or pro-apoptotic regulator gene expressions were analyzed by real-time PCR. Our data illustrated that high concentration of SA significantly inhibited liver cancer cell proliferation accompanied by apoptosis induction. In addition, SA led to the release of NO and the increase of NOS activities in above process. Importantly, SA up-regulated a series of apoptosis-related gene expression and reduced the mRNA level of HMGB1. Meanwhile, we also found that NOS inhibitor L-NAME and NO scavenger cPTIO attenuated the above SA-induced effects. Thus, we provided the evidence that SA exerted anti-tumor effects in liver cancer cell in part mediated by the NO pathway.

Entities:  

Keywords:  Apoptotic inducible effect; Hepatoma cell line; Nitric oxide; Salicylic acid

Year:  2017        PMID: 28185215      PMCID: PMC5559394          DOI: 10.1007/s12079-017-0380-z

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  34 in total

1.  World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.

Authors:  Peter Ferenci; Michael Fried; Douglas Labrecque; J Bruix; M Sherman; M Omata; J Heathcote; T Piratsivuth; Mike Kew; Jesse A Otegbayo; S S Zheng; S Sarin; S Hamid; Salma Barakat Modawi; Wolfgang Fleig; Suliman Fedail; Alan Thomson; Aamir Khan; Peter Malfertheiner; George Lau; F J Carillo; Justus Krabshuis; Anton Le Mair
Journal:  J Gastrointestin Liver Dis       Date:  2010-09       Impact factor: 2.008

2.  High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.

Authors:  Maria Ausiliatrice Puglisi; Carlo Cenciarelli; Valentina Tesori; Marianna Cappellari; Maurizio Martini; Angela Maria Di Francesco; Ezio Giorda; Rita Carsetti; Lucia Ricci-Vitiani; Antonio Gasbarrini
Journal:  J Pathol       Date:  2015-05-12       Impact factor: 7.996

3.  Selective expression of inducible nitric oxide synthase in human prostate carcinoma.

Authors:  T Klotz; W Bloch; C Volberg; U Engelmann; K Addicks
Journal:  Cancer       Date:  1998-05-15       Impact factor: 6.860

4.  Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines.

Authors:  L Klampfer; J Cammenga; H G Wisniewski; S D Nimer
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

5.  Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses.

Authors:  Hyong Woo Choi; Miaoying Tian; Fei Song; Emilie Venereau; Alessandro Preti; Sang-Wook Park; Keith Hamilton; G V T Swapna; Murli Manohar; Magali Moreau; Alessandra Agresti; Andrea Gorzanelli; Francesco De Marchis; Huang Wang; Marc Antonyak; Robert J Micikas; Daniel R Gentile; Richard A Cerione; Frank C Schroeder; Gaetano T Montelione; Marco E Bianchi; Daniel F Klessig
Journal:  Mol Med       Date:  2015-06-18       Impact factor: 6.354

Review 6.  Inducible nitric oxide synthase: what difference does it make?

Authors:  C Nathan
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 7.  Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer.

Authors:  J R Paterson; J R Lawrence
Journal:  QJM       Date:  2001-08

Review 8.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

9.  The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy.

Authors:  Riccardo Giampieri; Angelo Restivo; Valeria Pusceddu; Michela Del Prete; Elena Maccaroni; Alessandro Bittoni; Luca Faloppi; Kalliopi Andrikou; Maristella Bianconi; Francesco Cabras; Rossana Berardi; Luigi Zorcolo; Francesco Scintu; Stefano Cascinu; Mario Scartozzi
Journal:  Clin Colorectal Cancer       Date:  2016-08-04       Impact factor: 4.481

Review 10.  Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies.

Authors:  Peter C Elwood; Gareth Morgan; Janet E Pickering; Julieta Galante; Alison L Weightman; Delyth Morris; Mark Kelson; Sunil Dolwani
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more
  1 in total

1.  Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence.

Authors:  Maurizio D Baroni; Sonia Colombo; Enzo Martegani
Journal:  Microb Cell       Date:  2018-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.